Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet JP, Sobhani I. Le Gouvello S, et al. Among authors: leroy k. Gut. 2008 Jun;57(6):772-9. doi: 10.1136/gut.2007.123794. Epub 2007 Oct 26. Gut. 2008. PMID: 17965063
Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P, Leroy K, Castellano F. Guiter C, et al. Among authors: leroy k. Blood. 2004 Jul 15;104(2):543-9. doi: 10.1182/blood-2003-10-3545. Epub 2004 Mar 25. Blood. 2004. PMID: 15044251 Free article.
Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
Amiot A, Lévy M, Copie-Bergman C, Dupuis J, Szablewski V, Le Baleur Y, Baia M, Belhadj K, Sobhani I, Leroy K, Haioun C, Delchier JC. Amiot A, et al. Among authors: leroy k. Aliment Pharmacol Ther. 2014 Mar;39(6):619-28. doi: 10.1111/apt.12635. Epub 2014 Jan 27. Aliment Pharmacol Ther. 2014. PMID: 24467480 Free article.
Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial.
Karoui M, Rullier A, Luciani A, Bonnetain F, Auriault ML, Sarran A, Monges G, Trillaud H, Le Malicot K, Leroy K, Sobhani I, Bardier A, Moreau M, Brindel I, Seitz JF, Taieb J. Karoui M, et al. Among authors: leroy k. BMC Cancer. 2015 Jul 10;15:511. doi: 10.1186/s12885-015-1507-3. BMC Cancer. 2015. PMID: 26156156 Free PMC article. Clinical Trial.
214 results